Skip to main content
Smart Investors Daily
NE

NASDAQ · NEPH

Nephros, Inc.

Healthcare · Medical - Instruments & Supplies

$3.25

Up+$0.01 (+0.31%)

Updated Nov 5, 2026, 3:43 AM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
52.9M
P/E ratio
35.79
Dividend yield
0.00%
52-week range
$2.66 – $4.87
Volume
10.47K
Avg. volume
78.57K

Price performance · NEPH

NEPH price history

1M range · 0 trading sessions · Daily adjusted prices

NEPH does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest NEPH news

The latest Smart Investors Daily articles mentioning NEPH.

NEPH research

Overview

Company profile and research snapshot.

Company profile

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
NEPH recent ratings
DateFirmRatingTarget
Aug 8, 2025Maxim GroupBuy—
Nov 12, 2024BenchmarkSpeculative Buy—
May 15, 2024BenchmarkSpeculative Buy—
Mar 8, 2024BenchmarkSpeculative Buy—
Jan 26, 2021B. Riley FBRBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 29, 2026

Nephros Schedules Third Quarter 2026 Financial Results Conference Call

SOUTH ORANGE, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third quarter financial results on Thursday, November 5, 2026, after market close and will host a conference call that same day at 4:30 pm ET. Participants may dial into the call as follows:Domestic access: 1 (646) 307-1963International access: (800) 715-9871 Upon joining,

Benzinga · Sep 17, 2026

Nephros Q2 2026 Earnings Call: Complete Transcript

Nephros (NASDAQ:NEPH) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data and

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.